Literature DB >> 7773507

Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency.

J Miyagawa1, M Kuwajima, T Hanafusa, K Ozaki, H Fujimura, A Ono, R Uenaka, I Narama, T Oue, K Yamamoto.   

Abstract

A mouse with juvenile visceral steatosis (the JVS mouse) has been recognized as a novel animal model for systemic carnitine deficiency. We examined cardiac, skeletal and smooth muscle cells in JVS and control mice by light and electron microscopy. Cardiac and skeletal muscle cells of these mice at 4 weeks of age exhibited a ragged-red appearance after trichrome staining. Electron microscopy, demonstrated increased numbers of mitochondria and lipid droplets in the cells. Compression or distortion of the myofibril bundles, primarily due to the increased number of mitochondria, suggests the possible existence of a functional disturbance of the cardiac and skeletal muscle. In the urinary bladder, only one or two large lipid droplets and slightly increased number of mitochondria were recognized in the perinuclear region of the smooth muscle cells. At 8 weeks of age, the mouse enzyme histochemistry specific for mitochondria, such as cytochrome c oxidase and succinic dehydrogenase, and oil red O staining, confirmed further increases in the number of mitochondria and lipid droplets in the heart. However, the accumulation of these organelles in the skeletal and smooth muscle cells was no greater than that noted in JVS mice at 4 weeks of age. In the cardiac muscle cells, autolysosomes or autophagic vacuoles containing electron-dense membranous, lamellar or whorled structures closely associated with mitochondria and pseudoinclusion bodies in the nucleus were recognized, and bundles of myofibrils were buried under numerous mitochondria, suggesting the existence of disturbed contractile function in the heart of JVS mice. These results indicate that this murine strain associated with systemic carnitine deficiency exhibits a generalized mitochondrial abnormality in the muscle system especially in the heart.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7773507     DOI: 10.1007/bf00191365

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

1.  Urea cycle disorder in C3H-H-2 degree mice with juvenile steatosis of viscera.

Authors:  Y Imamura; T Saheki; H Arakawa; T Noda; T Koizumi; H Nikaido; J Hayakawa
Journal:  FEBS Lett       Date:  1990-01-15       Impact factor: 4.124

2.  Infantile disease with microvesicular fatty infiltration of viscera spontaneously occurring in the C3H-H-2(0) strain of mouse with similarities to Reye's syndrome.

Authors:  T Koizumi; H Nikaido; J Hayakawa; A Nonomura; T Yoneda
Journal:  Lab Anim       Date:  1988-01       Impact factor: 2.471

Review 3.  Carnitine deficiency syndromes.

Authors:  G N Breningstall
Journal:  Pediatr Neurol       Date:  1990 Mar-Apr       Impact factor: 3.372

4.  Abnormal expression of urea cycle enzyme genes in juvenile visceral steatosis (jvs) mice.

Authors:  M Tomomura; Y Imamura; M Horiuchi; T Koizumi; H Nikaido; J Hayakawa; T Saheki
Journal:  Biochim Biophys Acta       Date:  1992-02-14

5.  Successful carnitine treatment in two siblings having lipid storage myopathy with hypertrophic cardiomyopathy.

Authors:  T Matsuishi; K Hirata; K Terasawa; H Kato; M Yoshino; E Ohtaki; F Hirose; I Nonaka; N Sugiyama; K Ohta
Journal:  Neuropediatrics       Date:  1985-02       Impact factor: 1.947

6.  Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome.

Authors:  A G Engel; C Angelini
Journal:  Science       Date:  1973-03-02       Impact factor: 47.728

7.  Proto-oncogene c-jun and c-fos messenger RNAs increase in the liver of carnitine-deficient juvenile visceral steatosis (jvs) mice.

Authors:  M Tomomura; K Nakagawa; T Saheki
Journal:  FEBS Lett       Date:  1992-10-12       Impact factor: 4.124

8.  Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system.

Authors:  M Horiuchi; K Kobayashi; S Yamaguchi; N Shimizu; T Koizumi; H Nikaido; J Hayakawa; M Kuwajima; T Saheki
Journal:  Biochim Biophys Acta       Date:  1994-04-12

9.  Primary systemic carnitine deficiency under successful therapy: clinical, biochemical, ultrahistochemical and renal clearance studies.

Authors:  W von Petrykowski; U P Ketelsen; E Schmidt-Sommerfield; D Penn; E Sawicka; E Struck; W Lehnert; K Haap; H M Strassburg
Journal:  Clin Neuropathol       Date:  1985 Mar-Apr       Impact factor: 1.368

10.  Cardiomyopathy associated with carnitine loss in kidneys and small intestine.

Authors:  R Rodrigues Pereira; H R Scholte; I E Luyt-Houwen; M H Vaandrager-Verduin
Journal:  Eur J Pediatr       Date:  1988-12       Impact factor: 3.183

View more
  1 in total

Review 1.  Carnitine deficiency-induced cardiomyopathy.

Authors:  D J Paulson
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.